Yuwan Zhao
Zhanjiang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
JS-K induces autophagy-dependent ferroptosis in bladder cancer: a multimodal mechanistic and translational study.
Journal: Precision clinical medicine
Published: December 18, 2025
JS-K enhances renal cell carcinoma radiosensitivity through the Wnt/β-catenin signaling pathway and inhibits DNA damage repair.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: June 09, 2025
Reciprocal regulation between AtFH5-labeled secretory vesicles and PI(4,5)P2 oscillation at the plasma membrane directs pollen germination.
Journal: Journal of integrative plant biology
Published: December 19, 2024
JS-K induces ferroptosis in renal carcinoma cells by regulating the c-Myc-GSTP1 Axis.
Journal: Scientific reports
Published: December 05, 2024
Genome-Wide Identification of FCS-Like Zinc Finger (FLZ) Family Genes in Three Brassica Plant Species and Functional Characterization of BolFLZs in Chinese Kale Under Abiotic Stresses.
Journal: International journal of molecular sciences
Published: November 01, 2024
The Ras-related nuclear GTPase RAN1 ensures pollen size and tube growth by maintaining the actin cytoskeleton.
Journal: Journal of cell science
Published: December 21, 2023
JS-K activates G2/M checkpoints through the DNA damage response and induces autophagy via CAMKKβ/AMPKα/mTOR pathway in bladder cancer cells.
Journal: Journal of Cancer
Published: May 22, 2023
Erratum: Metformin in combination with JS-K inhibits growth of renal cell carcinoma cells via reactive oxygen species activation and inducing DNA breaks: Erratum.
Journal: Journal of Cancer
Published: September 01, 2022
Berberine inhibits the progression of renal cell carcinoma cells by regulating reactive oxygen species generation and inducing DNA damage.
Journal: Molecular biology reports
Published: July 22, 2022
'Corrigendum to "Resveratrol inhibits proliferation, migration and invasion via Akt and ERK1/2 signaling pathways in renal carcinoma cells" [Biomed. Pharmacother. 98 (2018) 36-44]'.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: June 27, 2022
[Mn(PaPy2Q)(NO)]ClO4, a Near-Infrared Light activated release of Nitric Oxide drug as a nitric oxide donor for therapy of human prostate cancer cells in vitro and in vivo.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: November 11, 2020
Last Updated: 09/26/2026